Shakun Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Shakun Biotech
Shakun Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 September 2003 and has a history of 21 years and four months. Its registered office is in Akola, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Sarda and Sanjay Sarda serve as directors at the Company.
Company Details
-
Location
Akola, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2003PTC142281
-
Company No.
142281
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Sep 2003
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Shakun Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Sarda
|
Whole-Time Director | 08-Jul-2013 | Current |
|
Sanjay Sarda
|
Director | 18-Sep-2003 | Current |
Financial Performance of Shakun Biotech.
Shakun Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shakun Biotech?
In 2017, Shakun Biotech had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Growth91 Advisors Private LimitedSanjay Sarda is a mutual person
-
Invidata Private LimitedSanjay Sarda is a mutual person
-
Growth Sense Private LimitedSanjay Sarda is a mutual person
-
Suyog Telematics LimitedSanjay Sarda is a mutual person
-
Educe Education Private LimitedAlok Sarda and Sanjay Sarda are mutual person
-
Shakun Universal Private Limited
Sanjay Sarda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shakun Biotech?
Unlock and access historical data on people associated with Shakun Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shakun Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shakun Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
